Skip to main content
Article
Geriatric Patients on Antithrombotic Agents Who Fall: Does Trauma Team Activation Improve Outcomes?
Reading Hospital General Surgery Residency
  • Peter Hwang, Philadelphia College of Osteopathic Medicine
  • Adrian Ong, Trauma & Surgical Critical Care, Reading Hospital, Reading, PA
  • Alison Muller, Trauma Services, Reading Hospital-Tower Health, Reading, PA
  • Amanda McNicholas, Trauma Services, Reading Hospital - Tower Health, Reading, PA
  • Anthony Martin, Trauma Services, Reading Hospital - Tower Health, Reading, PA
  • Adam Sigal, Dept. of Emergency Medicine, Reading Hospital-Tower Health, Reading, PA,
  • Forrest B Fernandez, Trauma & Surgical Critical Care, Reading Hospital, Reading, PA
Document Type
Article
Publication Date
7-1-2019
Disciplines
Abstract

Despite the incorporation of anticoagulant and antiplatelet (ACAP) drugs in our trauma triage criteria, it is unclear whether trauma team activation (TTA) impacts outcomes in geriatric patients on ACAP drugs sustaining falls. We hypothesized that TTA in this cohort was associated with improved outcomes. The hospital electronic database was queried to identify normotensive, awake patients aged ≥65 years on ACAP agent from 2014 to 2018 presenting to the emergency department after falls. The outcome was in-hospital mortality. The association between TTA and mortality was examined using logistic regression analysis and 1:1 propensity score matching analysis. In this study, 4540 patients on ACAP drugs were analyzed, with TTA occurring in 500 (11%). TTA occurred in younger but more severely injured patients with lower Glasgow Coma Score. Logistic regression revealed that TTA was not associated with mortality (odds ratio [95% confidence intervals], 2.04 [0.89-4.25]). The 1:1 propensity score analysis revealed similar mortality for the matched groups (non-TTA, 1.6%

Citation Information
Peter Hwang, Adrian Ong, Alison Muller, Amanda McNicholas, et al.. "Geriatric Patients on Antithrombotic Agents Who Fall: Does Trauma Team Activation Improve Outcomes?" Vol. 85 Iss. 7 (2019) p. 721 - 724
Available at: http://works.bepress.com/adam-sigal/41/